All

API

FDF

Price

Services

Excipients

Enquiries

Find

Active Pharmaceutical Ingredients
Finished Drug Formulations
Price
Excipients
Services
Marketplace

Market Place

Post Enquiry

Grow Your Pharma Business Digitally

Scorr-Insert

X

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

A collaboration with SCORR Marketing

All Data

Filters

refresh

×

FILTER DATA :

News Type

Company

Product Type

Deal Size

Upfront Payment

refresh

Product Type

Companies

Union Therapeutics

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

DENMARK Denmark

Post An Enquiry

BIO International Convention

Participation Not Confirmed

Update your events

UNION Therapeutics Launches COVID-19 Program in Collaboration With Institut Pasteur Korea

Contact the Supplier

Lead Product(s): Niclosamide

Therapeutic Area: Infections and Infectious Diseases

Highest Development Status: Preclinical Product Type: Small molecule

Partner/Sponsor/Collaborator: Institut Pasteur Korea

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Collaboration April 12, 2020

Details:

UNION therapeutics launch of a program to test an optimized salt form of niclosamide as a treatment of COVID-19, in collaboration with Institut Pasteur Korea.